| 329 | Humans (MeSH) |
| 221 | Simulation model |
| 201 | Econometric model |
| 193 | Modeling |
| 189 | Female (MeSH) |
| 178 | Simulation |
| 165 | Middle Aged (MeSH) |
| 165 | Aged (MeSH) |
| 153 | Road traffic |
| 147 | Male (MeSH) |
| 99 | Adult (MeSH) |
| 96 | Cost-Benefit Analysis (MeSH) |
| 92 | Computer Simulation (MeSH) |
| 85 | Comparative study |
| 77 | Traffic flow |
| 75 | Numerical simulation |
| 74 | Transportation |
| 66 | United States (MeSH) |
| 66 | Human |
| 66 | France |
| 65 | Methodology |
| 65 | Aged, 80 and over (MeSH) |
| 55 | Traffic management |
| 55 | Quality-Adjusted Life Years (MeSH) |
| 54 | Script |
| 51 | Application |
| 50 | Models, Theoretical (MeSH) |
| 50 | Microscopic model |
| 46 | Data analysis |
| 45 | Models, Statistical (MeSH) |
| 44 | United States |
| 44 | Adolescent (MeSH) |
| 43 | Calibration |
| 42 | Risk Factors (MeSH) |
| 42 | Result |
| 42 | Case study |
| 41 | Models, Economic (MeSH) |
| 41 | Markov Chains (MeSH) |
| 41 | Forecast model |
| 40 | Transport demand |
| 40 | Statistical method |
| 39 | Models |
| 39 | Household |
| 38 | Traffic lights |
| 38 | Performance evaluation |
| 38 | Medical screening |
| 37 | Age Factors (MeSH) |
| 36 | Mass Screening (economics) |
| 35 | Sensitivity and Specificity (MeSH) |
| 33 | Monte Carlo method |
| 33 | Activity |
| 32 | Travel time |
| 32 | Statistical estimation |
| 32 | Optimization |
| 32 | Intersection |
| 32 | Implementation |
| 32 | Health |
| 32 | Health economy |
| 32 | Evaluation |
| 32 | Cost efficiency analysis |
| 31 | Speed |
| 31 | Planning |
| 31 | Econometrics |
| 30 | Validation |
| 30 | Traffic congestion |
| 30 | Dynamic model |
| 29 | Urban area |
| 29 | Models, Econometric (MeSH) |
| 29 | Incidence (MeSH) |
| 27 | Treatment |
| 27 | Traffic safety |
| 27 | Recommendation |
| 27 | Freeway |
| 26 | United Kingdom |
| 26 | Child (MeSH) |
| 25 | Treatment Outcome (MeSH) |
| 25 | Retirement |
| 25 | Public health |
| 25 | Price |
| 25 | International conference |
| 25 | Costs |
| 24 | Travel |
| 24 | Risk Assessment (MeSH) |
| 24 | Pollutant emission |
| 24 | Mass Screening (methods) |
| 24 | Long term |
| 24 | Expenditure |
| 23 | Monte Carlo Method (MeSH) |
| 23 | Land use |
| 23 | Intelligent system |
| 23 | Impact study |
| 23 | Behavioral analysis |
| 22 | Time Factors (MeSH) |
| 22 | Statistics |
| 22 | Health Care Costs (MeSH) |
| 22 | Forecasting (MeSH) |
| 22 | Elderly |
| 22 | Economic impact |
| 22 | Data gathering |
| 21 | Survey |
| 21 | Life Expectancy (MeSH) |
| 21 | Forecasting |
| 21 | Financing |
| 21 | Cancerology |
| 21 | Behavior |
| 20 | Strategy |
| 20 | Prevalence (MeSH) |
| 20 | Income |
| 20 | Experimentation |
| 20 | Epidemiology |
| 20 | Choice |
| 20 | California |
| 19 | Road transportation |
| 19 | Road network |
| 19 | Public transportation |
| 19 | Prognosis |
| 19 | Passenger transportation |
| 19 | Demand |
| 19 | Decision making |
| 19 | Decision Support Techniques (MeSH) |
| 19 | Colorectal Neoplasms (diagnosis) |
| 19 | Care |
| 19 | Canada |
| 18 | Traffic control |
| 18 | Quality of Life (MeSH) |
| 18 | Population Dynamics (MeSH) |
| 18 | Perspective projection |
| 18 | Health Policy (MeSH) |
| 18 | Computer simulation |
| 18 | Cohort Studies (MeSH) |
| 17 | Young Adult (MeSH) |
| 17 | Road vehicle |
| 17 | Personal income |
| 17 | Pedestrian traffic |
| 17 | Motor car |
| 17 | Model |
| 17 | Modal choice |
| 17 | Market survey |
| 17 | Demography |
| 17 | Algorithm |
| 16 | Woman |
| 16 | Risk factor |
| 16 | Reproducibility of Results (MeSH) |
| 16 | Prognosis (MeSH) |
| 16 | Income (MeSH) |
| 16 | Energy policy |
| 16 | Economic aspect |
| 16 | Disease Progression (MeSH) |
| 16 | Demography (MeSH) |
| 16 | Carbon dioxide |
| 15 | Survival Rate (MeSH) |
| 15 | Socioeconomic Factors (MeSH) |
| 15 | Priority |
| 15 | Population |
| 15 | Oil economy |
| 15 | Models, Biological (MeSH) |
| 15 | Mathematical model |
| 15 | Formulation |
| 15 | Employment |
| 15 | Delay |
| 15 | Cost of Illness (MeSH) |
| 15 | Cost analysis |
| 15 | Child, Preschool (MeSH) |
| 15 | Canada (MeSH) |
| 15 | Bone Density Conservation Agents (economics) |
| 15 | Animals (MeSH) |
| 14 | Traffic assignment |
| 14 | Software (MeSH) |
| 14 | Sex Factors (MeSH) |
| 14 | Route |
| 14 | Retirement (economics) |
| 14 | Research (MeSH) |
| 14 | Production |
| 14 | Private sector |
| 14 | Policy |
| 14 | Non parametric estimation |
| 14 | Infant (MeSH) |
| 14 | Health insurance |
| 14 | Family Characteristics (MeSH) |
| 14 | Experimental study |
| 14 | Energy economy |
| 14 | Computing method |
| 14 | Approximation theory |
| 13 | Urban road traffic |
| 13 | United States (epidemiology) |
| 13 | Texas |
| 13 | Statistical distribution |
| 13 | Statistical data |
| 13 | Sensitivity analysis |
| 13 | Roundabout |
| 13 | Prevention |
| 13 | Population (MeSH) |
| 13 | Parameter estimation |
| 13 | Mortality |
| 13 | Maximum likelihood |
| 13 | Example |
| 13 | Bus |
| 13 | Age |
| 12 | Vehicle driver |
| 12 | Urban transportation |
| 12 | Stochastic method |
| 12 | Statistics as Topic (MeSH) |
| 12 | Statistical analysis |
| 12 | Spatial analysis |
| 12 | Senescence |
| 12 | Regression model |
| 12 | Numerical analysis |
| 12 | Method study |
| 12 | Medicine |
| 12 | Malignant tumor |
| 12 | Investment |
| 12 | Health Care Costs (statistics & numerical data) |
| 12 | Efficiency |
| 12 | Economic sciences |
| 12 | Decision Making (MeSH) |
| 12 | Colorectal cancer |
| 12 | Breast Neoplasms (mortality) |
| 12 | Breast Neoplasms (diagnosis) |
| 11 | Wage |
| 11 | Transportation network |
| 11 | Traffic accident |
| 11 | Timing |
| 11 | Theoretical study |
| 11 | System description |
| 11 | Simulator |
| 11 | Scheduling |
| 11 | Proportional Hazards Models (MeSH) |
| 11 | Project evaluation |
| 11 | Probability (MeSH) |
| 11 | Pricing |
| 11 | Poverty |
| 11 | Performance |
| 11 | Origin destination model |
| 11 | Netherlands (epidemiology) |
| 11 | Multivariate analysis |
| 11 | Morbidity |
| 11 | Model study |
| 11 | Infant, Newborn (MeSH) |
| 11 | Health policy |
| 11 | HIV Infections (drug therapy) |
| 11 | Genetic algorithm |
| 11 | Family (MeSH) |
| 11 | Evolution |
| 11 | Environment impact |
| 11 | Economy of transports |
| 11 | Economic analysis |
| 11 | Early Detection of Cancer (methods) |
| 11 | Capacity |
| 11 | Bone Density Conservation Agents (therapeutic use) |
| 11 | Behavior model |
| 11 | Aortic valve |
| 10 | Welfare aids |
| 10 | Theory |
| 10 | Supply |
| 10 | Stochastic process |
| 10 | Statistical simulation |
| 10 | Social Security (economics) |
| 10 | Risk |
| 10 | Risk analysis |
| 10 | Risk (MeSH) |
| 10 | Profitability |
| 10 | Pollution prevention |
| 10 | Petroleum |
| 10 | Osteoporosis |
| 10 | Osteoporosis (economics) |
| 10 | Occult Blood (MeSH) |
| 10 | Logit model |
| 10 | Housing |
| 10 | Freight transportation |
| 10 | Finance |
| 10 | Estimation |
| 10 | Employment (economics) |
| 10 | Economic data |
| 10 | Drug |
| 10 | Costs and Cost Analysis (MeSH) |
| 10 | Conflict |
| 10 | Colorectal Neoplasms (epidemiology) |
| 10 | Colorectal Neoplasms (economics) |
| 10 | Cardiovascular disease |
| 10 | Car following |
| 10 | Agent oriented |
| 9 | Vehicle type |
| 9 | Transportation system |
| 9 | Transportation policy |
| 9 | Time series |
| 9 | Sweden |
| 9 | Survival Analysis (MeSH) |
| 9 | Statistical model |
| 9 | Social Policy |
| 9 | Site selection |
| 9 | Outcome Assessment (Health Care) (MeSH) |
| 9 | Osteoporosis (drug therapy) |
| 9 | Mass Screening (MeSH) |
| 9 | Mammary gland |
| 9 | Information system |
| 9 | Health Status (MeSH) |
| 9 | HIV Infections (economics) |
| 9 | Follow-Up Studies (MeSH) |
| 9 | Europe |
| 9 | Error estimation |
| 9 | Economic model |
| 9 | Consumption |
| 9 | Colorectal Neoplasms (prevention & control) |
| 9 | Australia (MeSH) |
| 9 | Analysis method |
| 9 | Air pollution |
| 8 | Use |
| 8 | Traffic lane |
| 8 | System evaluation |
| 8 | Residential sector |
| 8 | Regulation(control) |
| 8 | Redistribution |
| 8 | Quantitative analysis |
| 8 | Public Policy (MeSH) |
| 8 | Prospective |
| 8 | Pollution control |
| 8 | Netherlands (MeSH) |
| 8 | Microsimulation |
| 8 | Mammography |
| 8 | Localization |
| 8 | Likelihood function |
| 8 | Interaction |
| 8 | Innovation |
| 8 | Income Redistribution |
| 8 | Health system |
| 8 | Germany |
| 8 | Experimental result |
| 8 | European Union |
| 8 | Europe (MeSH) |
| 8 | Environmental policy |
| 8 | Electricity |
| 8 | Early Detection of Cancer (economics) |
| 8 | Early Detection of Cancer (MeSH) |
| 8 | Drug Therapy, Combination (MeSH) |
| 8 | Drug Costs (MeSH) |
| 8 | Descriptive statistics |
| 8 | Data Collection (MeSH) |
| 8 | Classification |
| 8 | Child |
| 8 | Check |
| 8 | Cellular automaton |
| 8 | Cardiology |
| 8 | Breast Neoplasms (prevention & control) |
| 8 | Bayes estimation |
| 8 | Analytical method |
| 8 | Accessibility |
| 8 | Acceleration |
| 7 | Work |
| 7 | Vehicle driving |
| 7 | Uterine Cervical Neoplasms (prevention & control) |
| 7 | Uterine Cervical Neoplasms (economics) |
| 7 | Trend analysis |
| 7 | Taxation |
| 7 | Stochastic model |
| 7 | Statistical regression |
| 7 | Software tool |
| 7 | Social charges |
| 7 | Road signalling |
| 7 | Regression Analysis (MeSH) |
| 7 | Reform |
| 7 | Randomized Controlled Trials as Topic (MeSH) |
| 7 | Prostatic Neoplasms (mortality) |
| 7 | Predictive Value of Tests (MeSH) |
| 7 | Policy Making (MeSH) |
| 7 | Osteoporosis, Postmenopausal (economics) |
| 7 | Netherlands |
| 7 | Mass Screening (standards) |
| 7 | Mammography (economics) |
| 7 | Labour market |
| 7 | In situ test |
| 7 | Heterogeneity |
| 7 | Health Expenditures (statistics & numerical data) |
| 7 | HIV Infections (epidemiology) |
| 7 | Fertility (MeSH) |
| 7 | Expenditures |
| 7 | Evaluation Studies as Topic (MeSH) |
| 7 | England |
| 7 | Energy consumption |
| 7 | Empirical model |
| 7 | Empirical method |
| 7 | Economic optimization |
| 7 | Distribution function |
| 7 | Distribution by sources |
| 7 | Diagnosis |
| 7 | Decision analysis |
| 7 | Cross-Sectional Studies (MeSH) |
| 7 | Cost benefit analysis |
| 7 | Corridor |
| 7 | Colorectal Neoplasms (mortality) |
| 7 | Colonoscopy (economics) |
| 7 | Circulatory system |
| 7 | China |
| 7 | Chemotherapy |
| 7 | Breast cancer |
| 7 | Breast Neoplasms (epidemiology) |
| 7 | Belgium |
| 7 | Aortic Valve (surgery) |
| 7 | Algorithms (MeSH) |
| 7 | AIDS |
| 6 | Uterine Cervical Neoplasms (virology) |
| 6 | Unemployment |
| 6 | Surgery |
| 6 | Structural model |
| 6 | Stochastic Processes (MeSH) |
| 6 | Statistical test |
| 6 | Statistical Model |
| 6 | Spain |
| 6 | Spain (MeSH) |
| 6 | Social Allowance |
| 6 | Severity of Illness Index (MeSH) |
| 6 | Risk Assessment (methods) |
| 6 | Regression |
| 6 | Quality of life |
| 6 | Prostatic Neoplasms (diagnosis) |
| 6 | Professional activity |
| 6 | Production capacity |
| 6 | Pregnancy (MeSH) |
| 6 | Prediction theory |
| 6 | Osteoporosis, Postmenopausal (drug therapy) |
| 6 | Objective function |
| 6 | Non linear model |
| 6 | Neoplasm Staging (MeSH) |
| 6 | Models, Cardiovascular (MeSH) |
| 6 | Mobility |
| 6 | Medium term |
| 6 | Measurement result |
| 6 | Marriage (MeSH) |
| 6 | Markov chain |
| 6 | Market structure |
| 6 | Mammography (MeSH) |
| 6 | Longitudinal Studies (MeSH) |
| 6 | Linear regression |
| 6 | Life expectancy |
| 6 | Labour force |
| 6 | Insurance, Health (economics) |
| 6 | Indicator |
| 6 | Human immunodeficiency virus |
| 6 | Heart Valve Prosthesis (MeSH) |
| 6 | Heart Valve Diseases (surgery) |
| 6 | Health Services Needs and Demand (MeSH) |
| 6 | Goodness of fit test |
| 6 | Fractures, Bone (prevention & control) |
| 6 | Fiscal policy |
| 6 | Finite sample |
| 6 | Female |
| 6 | Family |
| 6 | Family benefit |
| 6 | Energy demand |
| 6 | Employee |
| 6 | Economic study |
| 6 | Economic development |
| 6 | Developing countries |
| 6 | Developing Countries (MeSH) |
| 6 | Developed Countries (MeSH) |
| 6 | Design |
| 6 | Demand forecasting |
| 6 | Decision criterion |
| 6 | Data Interpretation, Statistical (MeSH) |
| 6 | Crossnational Comparisons |
| 6 | Cross roads |
| 6 | Coronary heart disease |
| 6 | Consumer |
| 6 | Commercial vehicle |
| 6 | Capacity of traffic |
| 6 | Birth Rate (MeSH) |
| 6 | Australia |
| 6 | Asymptotic behavior |
| 6 | Anti-HIV Agents (therapeutic use) |
| 6 | Ambulatory |
| 6 | Alendronate (economics) |
| 6 | Aging (MeSH) |
| 6 | Age Distribution (MeSH) |
| 5 | Water resource management |
| 5 | Utah |
| 5 | Tumoral marker |
| 5 | Treatment efficiency |
| 5 | Travel to work |
| 5 | Traffic noise |
| 5 | Tourism |
| 5 | Time analysis |
| 5 | Technology |
| 5 | System design |
| 5 | Sustainable development |
| 5 | Spatial distribution |
| 5 | Social policy |
| 5 | Social Security (trends) |
| 5 | Smoking (adverse effects) |
| 5 | Short term |
| 5 | Sensitivity |
| 5 | SEER Program (MeSH) |
| 5 | Rural area |
| 5 | Routing |
| 5 | Retrospective Studies (MeSH) |
| 5 | Retirement Plan |
| 5 | Research Design (MeSH) |
| 5 | Replacement |
| 5 | Reoperation (MeSH) |
| 5 | Regional study |
| 5 | Regional economy |
| 5 | Queue |
